期刊
AMERICAN JOURNAL OF GASTROENTEROLOGY
卷 110, 期 5, 页码 646-659出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/ajg.2015.112
关键词
-
资金
- Gilead Sciences
- Intercept Pharmaceuticals
Primary sclerosing cholangitis is a chronic cholestatic liver disease that can shorten life and may require liver transplantation. The cause is unknown, although it is commonly associated with colitis. There is no approved or proven therapy, although ursodeoxycholic acid is used by many on an empiric basis. Complications including portal hypertension, fat-soluble vitamin deficiency, metabolic bone diseases, and development of cancers of the bile duct or colon can occur.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据